fda ends semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these 💉 The FDA has approved

GLP-1 RAs have been associated with the development of pancreatitis

Protein supports: Muscle preservation Recovery from exercise Metabolic health Strength maintenance Many people benefit from increasing protein intake while taking semaglutide, especially if exercising regularly

doi:10.1080/09513590.2023.2228917 19

Typical medication-assisted weight loss is less than or equal to 25% of total body weight

To summarise, if youre not an unemployed person who lives in a gym, kitchen, or zoo, Shortcut to Shred might not be for you

According to the FDA prescribing information, treatment is associated with a resting heart rate increase of about 1 to 4 beats per minute, with some patients experiencing larger increases